RBR-7nzwkpg
Recruiting
未知
Effects of treatment with oral anticoagulant associated with antibiotic therapy on clinical, immunological parameters, hospitalization and mortality in patients with suspected Covid-19 infection and positive d-dimer: a randomized clinical trial
niversidade do Sul de Santa Catarina0 sitesStarted: January 6, 2021Last updated:
Overview
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- niversidade do Sul de Santa Catarina
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Intervention
Eligibility Criteria
- Ages
- 18Y to 100Y (—)
Inclusion Criteria
- •Patients over 18 years of age; clinical suspicion of Covid\-19; oxygen saturation between 93% and 97%; at least one more symptom according to the Ministry of Health criteria including tiredness or shortness of breath; fever and chills reported; cough and loss of smell or taste; positive result for the D\-dimer test
Exclusion Criteria
- •Patients with active infectious diseases; immunosuppressive diseases or active cancer; pregnant or lactating women; known renal failure; current use of anticoagulants; contraindication to the use of Edoxaban or Moxifloxacin
Investigators
Similar Trials
Active, not recruiting
Phase 1
Effect of anticoagulation therapy on clinical outcomes in COVID-19 (COVID-PREVENT)EUCTR2020-002282-33-DECharité - Universitaetsmedizin Berlin400
Recruiting
Phase 2
Comparison of the effects of Rivaroxaban and Apixaban with Heparin and Enoxaparin in patients undergoing gynecological oncological surgery.IRCT20220211053991N1Iran University of Medical Sciences80
Active, not recruiting
Phase 1
Monitoring the effect of blood thinners during percutaneous coronary interventioAnticoagulation during percutaneous coronary interventionTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2020-005298-29-NLSt. Antonius Hospital120
Recruiting
Phase 4
Monitoring the effect of oral anticoagulants during cardiac catheterisatiocoronary artery diseasepercutaneous coronary intervention10011082NL-OMON50931Sint Antonius Ziekenhuis120
Not yet recruiting
Not Applicable
The benefit of EXtending oral blood thinning(antiCOAgulant) treatment after acute blockage of cerebral veins(cerebral venous thrombosis-CVT) (EX-COA CVT)Health Condition 1: null- patients with cerebral venous sinus thrombosis,within month of eventCTRI/2017/08/009564niversity of Lisbon